Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.5100
+0.0100 (2.00%)
At close: Sep 15, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 39.73 million as of September 16, 2026. Its market cap has decreased by -32.40% in one year.
Market Cap
39.73M
Enterprise Value
32.72M
Revenue
19.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
ChartMarket Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 39.73M, a decrease of -83.13%. That is a compound annual growth rate of -30.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 36.88M | -16.72% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hunter Capital RTO 1 AB | 50.40M |
| Beyond Frames Entertainment AB | 50.13M |
| Lightning Group AB | 49.99M |
| Kontigo Care AB | 48.65M |
| Touchtech AB | 47.00M |
| OurLiving AB | 43.90M |
| Gomero Group AB | 36.46M |
| Vidhance AB | 30.68M |